Cees van Nieuwkoop - Concepedia

Author

Cees van Nieuwkoop

Also Known As

Astrid M L Oude Lashof, Astrid M.L. Oude Lashof, C van Nieuwkoop, C. Van Nieuwkoop, C. van Nieuwkoop, Cees Van Nieuwkoop, Cees van Nieuwkoop, Cornelis van Nieuwkoop, E F Schippers, E. F. Schippers

145

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Haga Hospital University of Amsterdam Medisch Centrum Haaglanden University Medical Center Utrecht

About

Cees van Nieuwkoop is an author at Leiden University Medical Center specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	943
2	Health Sciences	3	3	242
3	Engineering	1	1	62
4	Nursing	1	1	108
5	Public Health	1	1	109

Cees van Nieuwkoop

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Risk factors and time delay associated with cardiac device infections: Leiden device registry Jaco C Lekkerkerker, Cees van Nieuwkoop, Serge A. Trines, Heart	2008	231
Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study Cees van Nieuwkoop, Tobias Bonten, J. W. van’t Wout, Critical Care Blood CultureAntimicrobial StewardshipHealthcare-associated InfectionClinical EpidemiologyUrosepsis Syndrome	2010	187
Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands: the COVID-OLD study Laura C. Blomaard, Carolien M. J. van der Linden, Jessica M. van der Bol, Age and Ageing	2021	117
Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection Willize E. van der Starre, Cees van Nieuwkoop, S. Paltansing, Journal of Antimicrobial Chemotherapy	2010	115
Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study Roos S. G. Sablerolles, Melvin Lafeber, Janneke A. L. van Kempen, The Lancet Healthy Longevity GeriatricsMedicineGlobal HealthHospital MortalityClinical Epidemiology	2021	109
Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial Marijn de Bruin, E. Oberjé, Wolfgang Viechtbauer, The Lancet Infectious Diseases NursingHealthcare ProvisionClinical EffectivenessTreatment And PreventionPatient Support	2017	108
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women Cees van Nieuwkoop, Willize E. van der Starre, Janneke E. Stalenhoef, BMC Medicine	2017	81
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study Colette Smit, Anders Boyd, Bart Rijnders, The Lancet HIV Retrospective Cohort StudyTreatment And PreventionHuman RetrovirusHcv Micro-eliminationAntiviral Therapy	2020	72
Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein Inhibitors Emiel Leegwater, Anne S. Strik, Erik B. Wilms, Clinical Infectious Diseases Coronavirus Disease 2019HepatologyMedicineLiver PhysiologyAntiviral Drug Development	2020	71
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19 S. Gevers, Marcel Kwa, E. G. Leonoor Wijnans, Clinical Microbiology and Infection Safety ConsiderationsCovid-19 PandemicAntiviral TherapyInfection ControlAntiviral Drug	2020	68

Page 1